This page includes the latest FDA filings for Sage Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | SAGE | DUNS 968164959 |
Device Company | Device | Date |
|---|---|---|
| Sage Therapeutics, Inc., Ash Stevens LLC, Alcami Carolinas Corporation | Prescription Medication | 2024-07-19 |
| Sage Therapeutics, Inc., Ash Stevens LLC, Alcami Carolinas Corporation | Prescription Medication | 2022-07-01 |
| Sage Therapeutics, Inc., Ash Stevens LLC, Alcami Carolinas Corporation | Prescription Medication | 2020-12-15 |
| Sage Therapeutics, Inc., Ash Stevens LLC, Alcami Carolinas Corporation | Prescription Medication | 2019-11-22 |
| Sage Therapeutics, Inc., Ash Stevens LLC, Alcami Carolinas Corporation | Prescription Medication | 2019-09-26 |
| Sage Therapeutics, Inc., Ash Stevens LLC, Alcami Carolinas Corporation | Prescription Medication | 2019-06-18 |
| Sage Therapeutics, Inc. | Zulresso | 2019-06-17 |
| NCAGE Code | 6DBP9 | SAGE THERAPEUTICS, INC. |
| CAGE Code | 6DBP9 | SAGE THERAPEUTICS, INC. |
| S.A.M. Registration | 6DBP9 [968164959] | SAGE THERAPEUTICS, INC. |
| SEC | 0001597553 | Sage Therapeutics, Inc. of DELAWARE |